BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 32369516)

  • 1. Type 2 diabetes, breast cancer specific and overall mortality: Associations by metformin use and modification by race, body mass, and estrogen receptor status.
    Lee KN; Torres MA; Troeschel AN; He J; Gogineni K; McCullough LE
    PLoS One; 2020; 15(5):e0232581. PubMed ID: 32369516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study of type 2 diabetes, metformin use, and risk of breast cancer.
    Park YM; Bookwalter DB; O'Brien KM; Jackson CL; Weinberg CR; Sandler DP
    Ann Oncol; 2021 Mar; 32(3):351-359. PubMed ID: 33516778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pathological characteristics and prognostic analysis of diabetic women with luminal subtype breast cancer.
    Xiao Y; Zhang S; Hou G; Zhang X; Hao X; Zhang J
    Tumour Biol; 2014 Mar; 35(3):2035-45. PubMed ID: 24096546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer.
    He X; Esteva FJ; Ensor J; Hortobagyi GN; Lee MH; Yeung SC
    Ann Oncol; 2012 Jul; 23(7):1771-80. PubMed ID: 22112968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between diabetes medication use and risk of second breast cancer events and mortality.
    Calip GS; Yu O; Hoskins KF; Boudreau DM
    Cancer Causes Control; 2015 Aug; 26(8):1065-77. PubMed ID: 25956271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type 2 diabetes as a predictor of survival among breast cancer patients: the multiethnic cohort.
    Maskarinec G; Shvetsov YB; Conroy SM; Haiman CA; Setiawan VW; Le Marchand L
    Breast Cancer Res Treat; 2019 Feb; 173(3):637-645. PubMed ID: 30367331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival after breast cancer in women with type 2 diabetes using antidiabetic medication and statins: a retrospective cohort study.
    Hosio M; Urpilainen E; Hautakoski A; Marttila M; Arffman M; Sund R; Ahtikoski A; Puistola U; Karihtala P; Jukkola A; Läärä E
    Acta Oncol; 2020 Sep; 59(9):1110-1117. PubMed ID: 32478629
    [No Abstract]   [Full Text] [Related]  

  • 8. Antidiabetic Medication, Statins and the Risk and Prognosis of Non-endometrioid Endometrial Cancer in Women with Type 2 Diabetes.
    Arima R; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Kangaskokko J; Urpilainen E; Läärä E; Hinkula M; Puistola U
    Anticancer Res; 2018 Jul; 38(7):4169-4178. PubMed ID: 29970546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of antidiabetic medication and statins with survival from ductal and lobular breast carcinoma in women with type 2 diabetes.
    Hosio M; Urpilainen E; Hautakoski A; Marttila M; Arffman M; Sund R; Ahtikoski A; Puistola U; Läärä E; Karihtala P; Jukkola A
    Sci Rep; 2021 May; 11(1):10445. PubMed ID: 34001921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer.
    Bayraktar S; Hernadez-Aya LF; Lei X; Meric-Bernstam F; Litton JK; Hsu L; Hortobagyi GN; Gonzalez-Angulo AM
    Cancer; 2012 Mar; 118(5):1202-11. PubMed ID: 21800293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between glucose-lowering drug use and mortality among breast cancer patients with type 2 diabetes.
    Vissers PA; Cardwell CR; van de Poll-Franse LV; Young IS; Pouwer F; Murray LJ
    Breast Cancer Res Treat; 2015 Apr; 150(2):427-37. PubMed ID: 25762476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of metformin on breast cancer outcomes in patients with type 2 diabetes.
    Oppong BA; Pharmer LA; Oskar S; Eaton A; Stempel M; Patil S; King TA
    Cancer Med; 2014 Aug; 3(4):1025-34. PubMed ID: 24944108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis of ovarian cancer in women with type 2 diabetes using metformin and other forms of antidiabetic medication or statins: a retrospective cohort study.
    Urpilainen E; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Arima R; Kangaskokko J; Puistola U; Hinkula M; Läärä E
    BMC Cancer; 2018 Jul; 18(1):767. PubMed ID: 30055585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative safety of diabetes medications and risk of incident invasive breast cancer: a population-based cohort study.
    Calip GS; Yu O; Elmore JG; Boudreau DM
    Cancer Causes Control; 2016 May; 27(5):709-20. PubMed ID: 27053250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of preexisting type 2 diabetes mellitus and antidiabetic drugs on all-cause and cause-specific mortality among Medicaid-insured women diagnosed with breast cancer.
    Lawrence WR; Hosler AS; Gates Kuliszewski M; Leinung MC; Zhang X; Schymura MJ; Boscoe FP
    Cancer Epidemiol; 2020 Jun; 66():101710. PubMed ID: 32247208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer mortality reduction and metformin: a retrospective cohort study in type 2 diabetic patients.
    Bo S; Ciccone G; Rosato R; Villois P; Appendino G; Ghigo E; Grassi G
    Diabetes Obes Metab; 2012 Jan; 14(1):23-9. PubMed ID: 21812892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin use and survival after colorectal cancer: A population-based cohort study.
    Mc Menamin ÚC; Murray LJ; Hughes CM; Cardwell CR
    Int J Cancer; 2016 Jan; 138(2):369-79. PubMed ID: 26331456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Metformin with Breast Cancer Incidence and Mortality in Patients with Type II Diabetes: A GRADE-Assessed Systematic Review and Meta-analysis.
    Tang GH; Satkunam M; Pond GR; Steinberg GR; Blandino G; Schünemann HJ; Muti P
    Cancer Epidemiol Biomarkers Prev; 2018 Jun; 27(6):627-635. PubMed ID: 29618465
    [No Abstract]   [Full Text] [Related]  

  • 19. Validating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortality.
    Xu H; Aldrich MC; Chen Q; Liu H; Peterson NB; Dai Q; Levy M; Shah A; Han X; Ruan X; Jiang M; Li Y; Julien JS; Warner J; Friedman C; Roden DM; Denny JC
    J Am Med Inform Assoc; 2015 Jan; 22(1):179-91. PubMed ID: 25053577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Good glycaemic control is associated with a better prognosis in breast cancer patients with type 2 diabetes mellitus.
    Chang YL; Sheu WH; Lin SY; Liou WS
    Clin Exp Med; 2018 Aug; 18(3):383-390. PubMed ID: 29572669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.